Low prevalence of chronic hepatitis C, but high prevalence of elevated aminotransferases in a cohort of 2026 patients referred for orthopaedic surgery in the eastern part of Germany

Zeitschrift fur Gastroenterologie

Volumn 44, Issue 1, 2006, Pages 11-14

  Wiegand, J ^a   Kaiser, T ^a   Lobstein, S ^a   Brand, F ^b   Wojan, M ^a   Stolzel U ^c   Liebert, U G ^a   Mossner J ^a   Tillmann, Hans L ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b Waldkrankenhaus Rudolf Elle GmbH   (Germany)

^c KLINIKUM CHEMNITZ   (Germany)

Author keywords

Elevated aminotransferases; Epidemiology; Prevelence

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; RHESUS D ANTIBODY; VIRUS RNA;

ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GERMANY; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; POLYMERASE CHAIN REACTION; PREVENTION; SERUM; VIREMIA;

COHORT STUDIES; FEMALE; GERMANY; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; PREVALENCE; REFERRAL AND CONSULTATION; RISK FACTORS; SEX DISTRIBUTION; TRANSAMINASES;

EID: 31944449993     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858876     Document Type: Article

References (17)

1. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002; 36: S21-S29
2. Alter MJ, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-562
3. World Health Organization. Fact sheet hepatitis C. Weekly Epidemiological Record, 1999: 49
4. Thierfelder W, Hellenbrand W, Meisel H et al. Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol 2001; 17: 429-435
5. Koerner K, Cardoso M, Dengler T et al. Estimated risk of transmission of hepatitis C virus by blood transfusion. Vox Sang 1998; 74: 213-216
6. Stark K, Schreier E, Muller R et al. Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin. Scand J Infect Dis 1995; 27: 331-337
7. Weber B, Rabenau H, Berger A et al. Seroprevalence of HCV, HAV, HBV, HDV, HCMV and HIV in high risk groups Frankfurt a. M., Germany: Zentralbl Bakteriol, 1995: 282: 102-112
8. Osella AR, Misciagna G, Leone A et al. Epidemiology of hepatitis C virus infection in an area of Southern Italy. J Hepatol 1997; 27: 30-35
9. Maio G, d'Argenio P, Stroffolini T et al. Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town. J Hepatol 2000; 33: 116-120
10. Guadagnino V, Stroffolini T, Rapicetta M et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997; 26: 1006-1011
11. Robert Koch Institut. Virushepatitis B, C und D im Jahr 2002. Epid. Bull, 16-1-2004: Nr. 2
12. Wiese M, Berr F, Lafrenz M et al. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 2000; 32: 91-96
13. Palitzsch KD, Hottentrager B, Schlottmann K et al. Prevalence of antibodies against hepatitis C virus in the adult German population. Eur J Gastroenterol Hepatol 1999; 11: 1215-1220
14. Hillemanns P, Langenegger P, Langer BC et al. Prevalence and follow-up of hepatitis C virus infection in pregnancy. Z Geburtshilfe Neonatol 1998; 202: 127-130
15. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98: 960-967
16. Narjes H, Nehmiz G. Effect of hospitalisation on liver enzymes in healthy subjects. Eur J Clin Pharmacol 2000; 56: 329-333
17. Rosenzweig P, Miget N, Brohier S. Transaminase elevation on placebo during phase I trials: prevalence and significance. Br J Clin Pharmacol 1999; 48: 19-23